Healthcare
Export of 160 presentations of antipsychotic and 49 other medicines prohibited
Infarmed has suspended the export of over 160 presentations of the antipsychotic quetiapine and 49 other medicines, including antibiotics, vaccines, and drugs for cancer, cardiac arrhythmias, dementia, and migraines, effective Friday 13 November 2026. The measure targets medicines that recently faced supply shortages or are being supplied via Exceptional Use Authorization (AUE), with the quetiapine shortage expected to persist until the end of the year due to manufacturing issues in Greece.
Why it matters
If you are prescribed quetiapine or other essential medicines that have faced recent shortages, this export ban is intended to protect local availability, though you should contact your pharmacy if you have trouble filling your prescription.ObservadorRead original ↗
Useful?
